Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study
Purpose To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. Methods We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan–Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. Results During the study period 248 patients were recruited in the eight participating ICUs. Ninety (36.3%) patients developed at least one episode of secondary infection. An ICU length of stay between 7 and 14 days was characterized by a higher occurrence of infectious complications, with ventilator-associated pneumonia being the most frequent. At least one course of antibiotic therapy was given to 161 (64.9%) patients. Overall ICU and hospital mortality were 33.9% and 42.9%, respectively. Patients developing bacteremia had a higher risk of ICU mortality [45.9% vs. 31.6%, odds ratio 1.8 (95% CI 0.9–3.7), p = 0.069] and hospital mortality [56.8% vs. 40.3%, odds ratio 1.9 (95% CI 1.1–3.9), p = 0.04]. Conclusion In critically ill patients infected with COVID-19 the incidence of bacterial infections is high and associated with worse outcomes. Regular microbiological surveillance and strict infection control measures are mandated..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
Infection - 50(2021), 1 vom: 14. Juli, Seite 139-148 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
De Santis, Vincenzo [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
© Springer-Verlag GmbH Germany, part of Springer Nature 2021 |
|---|
| doi: |
10.1007/s15010-021-01661-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR046115358 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR046115358 | ||
| 003 | DE-627 | ||
| 005 | 20230519182916.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220201s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s15010-021-01661-2 |2 doi | |
| 035 | |a (DE-627)SPR046115358 | ||
| 035 | |a (SPR)s15010-021-01661-2-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a De Santis, Vincenzo |e verfasserin |0 (orcid)0000-0002-5105-7969 |4 aut | |
| 245 | 1 | 0 | |a Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Springer-Verlag GmbH Germany, part of Springer Nature 2021 | ||
| 520 | |a Purpose To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. Methods We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan–Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. Results During the study period 248 patients were recruited in the eight participating ICUs. Ninety (36.3%) patients developed at least one episode of secondary infection. An ICU length of stay between 7 and 14 days was characterized by a higher occurrence of infectious complications, with ventilator-associated pneumonia being the most frequent. At least one course of antibiotic therapy was given to 161 (64.9%) patients. Overall ICU and hospital mortality were 33.9% and 42.9%, respectively. Patients developing bacteremia had a higher risk of ICU mortality [45.9% vs. 31.6%, odds ratio 1.8 (95% CI 0.9–3.7), p = 0.069] and hospital mortality [56.8% vs. 40.3%, odds ratio 1.9 (95% CI 1.1–3.9), p = 0.04]. Conclusion In critically ill patients infected with COVID-19 the incidence of bacterial infections is high and associated with worse outcomes. Regular microbiological surveillance and strict infection control measures are mandated. | ||
| 650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Critically ill patients |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Secondary bacterial infection |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Co-infection |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Corona, Alberto |4 aut | |
| 700 | 1 | |a Vitale, Domenico |4 aut | |
| 700 | 1 | |a Nencini, Cecilia |4 aut | |
| 700 | 1 | |a Potalivo, Antonella |4 aut | |
| 700 | 1 | |a Prete, Anna |4 aut | |
| 700 | 1 | |a Zani, Gianluca |4 aut | |
| 700 | 1 | |a Malfatto, Anna |4 aut | |
| 700 | 1 | |a Tritapepe, Luigi |4 aut | |
| 700 | 1 | |a Taddei, Stefania |4 aut | |
| 700 | 1 | |a Locatelli, Alessandro |4 aut | |
| 700 | 1 | |a Sambri, Vittorio |4 aut | |
| 700 | 1 | |a Fusari, Maurizio |4 aut | |
| 700 | 1 | |a Singer, Mervyn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infection |d München : Urban & Vogel, 1973 |g 50(2021), 1 vom: 14. Juli, Seite 139-148 |w (DE-627)SPR032536909 |w (DE-600)2006315-5 |x 1439-0973 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2021 |g number:1 |g day:14 |g month:07 |g pages:139-148 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s15010-021-01661-2 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2021 |e 1 |b 14 |c 07 |h 139-148 | ||